Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Linkou, Taiwan Clinical Trials

A listing of Linkou, Taiwan clinical trials actively recruiting patients volunteers.

RESULTS

Found (4) clinical trials

A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

The reason for this study is to see if the study drug selpercatinib compared to a standard treatment is effective and safe in participants with rearranged during transfection (RET) fusion-positive non-squamous non-small cell lung cancer (NSCLC) that has spread to other parts of the body. Participants who are assigned to ...

Phase

4.32 miles

Learn More »

Mesenchymal Stem Cells for The Treatment of Acute Ischemic Stroke

Stroke is the second most important cause of mortality and morbidity in the world. Currently, the standard treatment for ischemic stroke is an intravenous tissue plasminogen activator(tPA; alteplase) and/or endovascular thrombectomy. However, the therapeutic time window for these treatments is narrow. Besides, endovascular thrombectomy requires specialized stroke expertise and endovascular ...

Phase

6.34 miles

Learn More »

The Evaluation of Single Acupoint Therapy to Acute Low Back Pain

Low back pain is the leading course of disability , affecting pateints' health and work. According to the study in 2013, 8.9 persent people of the world experienced over three months low back pain. Recently, studies have reveal the fact that patients get insufficient physical activity and easily let acute ...

Phase N/A

8.04 miles

Learn More »

A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Gu rin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)

This study enrolls participants with high risk NMIBC FGFR mutations or fusions. Erdafitinib is an oral pan-fibroblast growth factor receptor (FGFR) 1-4 inhibitor with demonstrated clinical activity in participants with solid tumors, including urothelial carcinoma, with alterations in the FGFR pathway. In Cohort 1, participants will be randomized to erdafitinib ...

Phase

8.04 miles

Learn More »